Primary vaccine failure after 1 dose of varicella vaccine in healthy children.

The Journal of Infectious Diseases
David E MichalikAnne A Gershon

Abstract

Universal immunization of young children with 1 dose of varicella vaccine was recommended in the United States in 1995, and it has significantly decreased the incidence of chickenpox. Outbreaks of varicella, however, are reported among vaccinated children. Although vaccine effectiveness has usually been 85%, rates as low as 44% have been observed. Whether this is from primary or secondary vaccine failure-or both-is unclear. We tested serum samples from 148 healthy children immunized against varicella in New York, Tennessee, and California to determine their seroconversion rates, before and after 1 dose of Merck/Oka varicella vaccine. The median age at vaccination was 12.5 months; postvaccination serum samples were obtained on average 4 months later. Serum was tested for antibodies against varicella-zoster virus (VZV) by use of the previously validated sensitive and specific fluorescent antibody to membrane antigen (FAMA) assay. Of 148 healthy child vaccinees, 113 (76%) seroconverted, and 24% had no detectable VZV FAMA antibodies. Our data contrast with reported seroconversion rates of 86%-96% by other VZV antibody tests and suggest that many cases of varicella in immunized children are due to primary vaccine failure. A second d...Continue Reading

References

Apr 1, 1976·Proceedings of the Society for Experimental Biology and Medicine·A A GershonW J Kuhns
Jul 1, 1991·Journal of Clinical Microbiology·S P Steinberg, A A Gershon
Aug 1, 1991·The Pediatric Infectious Disease Journal·A K JunkerE E Thomas
Nov 1, 1985·The Journal of Infectious Diseases·P LaRussaA A Gershon
Dec 1, 1974·The Journal of Infectious Diseases·V WilliamsP A Brunell
Feb 1, 1984·The Journal of Infectious Diseases·A A GershonL Gelb
Jul 20, 1984·JAMA : the Journal of the American Medical Association·A A GershonA Farrara
Nov 18, 1997·JAMA : the Journal of the American Medical Association·H S IzurietaP A Blake
Mar 29, 2001·The New England Journal of Medicine·M VázquezE D Shapiro
Jun 29, 2001·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·L SaimanA A Gershon
Feb 7, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Krow AmpofoAnne Gershon
Jun 13, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mark S DworkinJohn R Lumpkin
Jun 29, 2002·The Journal of Infectious Diseases·Karin GalilJane Seward
Dec 13, 2002·The New England Journal of Medicine·Karin GalilJane Seward
Aug 23, 1962·The New England Journal of Medicine·A H ROSS
Feb 12, 2004·The Pediatric Infectious Disease Journal·Barbara KuterUNKNOWN Study Group for Varivax
Feb 19, 2004·JAMA : the Journal of the American Medical Association·Marietta VázquezEugene D Shapiro
Mar 3, 2004·Pediatrics·Barna D TugwellPaul R Cieslak
Jul 10, 2004·The Journal of Infectious Diseases·Brian R LeeKristen R Ehresmann
Aug 12, 2004·JAMA : the Journal of the American Medical Association·Jane F SewardAisha O Jumaan
Aug 1, 1994·Clinical and Diagnostic Virology·A A GershonS Steinberg
Jan 13, 2005·The Journal of Pediatrics·Anne Gershon
Aug 31, 2006·The Pediatric Infectious Disease Journal·Alberto Arnedo-PenaMaría Angeles Romeu-García
Mar 16, 2007·The New England Journal of Medicine·Sandra S ChavesJane F Seward

❮ Previous
Next ❯

Citations

Jun 22, 2007·The New England Journal of Medicine·Anne A GershonEugene Shapiro
Jun 19, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stanley A Plotkin
Feb 23, 2010·The Journal of Infectious Diseases·Adriana WeinbergMyron J Levin
Jan 7, 2011·The Journal of Infectious Diseases·Eugene D ShapiroAnne A Gershon
Jun 30, 2009·The Pediatric Infectious Disease Journal·Anne A GershonUNKNOWN Pediatric AIDS Clinical Trials Group 391 Team
Jan 13, 2010·Clinical Microbiology Reviews·D Scott Schmid, Aisha O Jumaan
May 14, 2010·Clinical and Vaccine Immunology : CVI·Stanley A Plotkin
Jan 15, 2014·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·D Moreno-PérezUNKNOWN Comité Asesor de Vacunas de la Asociación Española de Pediatría
Dec 12, 2012·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·D Moreno-PérezUNKNOWN Comité Asesor de Vacunas de la Asociación Española de Pediatría, España
Dec 20, 2011·Anales de pediatría : publicación oficial de la Asociación Española de Pediatría (A.E.P.)·D Moreno-PérezUNKNOWN Advisory Committee on Vaccines of the Spanish Association of Pediatrics
Apr 13, 2011·Child Abuse & Neglect·Sabrina Barrett, Scott Burgess
Jul 6, 2010·The Journal of Infection·Karen L AyresJudith Breuer
Apr 13, 2010·The Journal of Infection·So Hee KimEun Hwa Choi
Aug 6, 2013·Pediatric Annals·Daniel P Boyle, John P Flaherty
Sep 22, 2012·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·K M Posfay-BarbeC A Siegrist
Mar 18, 2010·Arthritis Care & Research·Gecilmara Salviato PileggiVirgínia Paes Leme Ferriani
Apr 5, 2016·Current Opinion in Virology·Gregory A PolandRichard B Kennedy
Jan 18, 2013·Human Vaccines & Immunotherapeutics·Manuel García CenozJesús Castilla
Jan 9, 2014·Human Vaccines & Immunotherapeutics·Silvio TafuriCinzia Germinario
May 20, 2011·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Zafer KurugolSadik Aksit
Apr 29, 2009·Expert Review of Vaccines·Nabil Ahmed, Stephen Gottschalk
Nov 28, 2017·Viral Immunology·Jana Shaw, Anne A Gershon
Oct 5, 2013·Clinical Microbiology Reviews·Anne A Gershon, Michael D Gershon
Mar 29, 2014·Clinical and Vaccine Immunology : CVI·Sung Hee OhShin Ah Kim
Sep 6, 2018·The Journal of Infectious Diseases·Helen S MarshallUNKNOWN PAEDS Investigators
Feb 13, 2013·Journal of Korean Medical Science·Hyunju LeeKyung-Hyo Kim
Sep 13, 2018·Pediatric Transplantation·Daniel E DulekNatasha B Halasa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.